400 related articles for article (PubMed ID: 29020185)
21. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.
Kumari R; Palaniyandi S; Hildebrandt GC
Dig Dis Sci; 2019 Mar; 64(3):669-677. PubMed ID: 30523482
[TBL] [Abstract][Full Text] [Related]
22. Shotgun sequencing of the faecal microbiome to predict response to steroids in patients with lower gastrointestinal acute graft-versus-host disease: An exploratory analysis.
Turner G; Smith M; Hoeschen AL; Wilson JA; Kennedy J; Abramson M; Cao Q; El Jurdi N; MacMillan ML; Weisdorf DJ; Blazar BR; Khoruts A; Shields-Cutler RR; Knights D; Holtan SG; Rashidi A
Br J Haematol; 2021 Feb; 192(3):e69-e73. PubMed ID: 33222185
[No Abstract] [Full Text] [Related]
23. [Analysis of the dynamic changes in gut microbiota in patients with extremely severe burns by 16S ribosomal RNA high-throughput sequencing technology].
Pan YY; Fan YF; Li JL; Cui SY; Huang N; Jin GY; Chen C; Zhang C
Zhonghua Shao Shang Za Zhi; 2020 Dec; 36(12):1159-1166. PubMed ID: 33379852
[No Abstract] [Full Text] [Related]
24. Gut Microbiota Predict Pulmonary Infiltrates after Allogeneic Hematopoietic Cell Transplantation.
Harris B; Morjaria SM; Littmann ER; Geyer AI; Stover DE; Barker JN; Giralt SA; Taur Y; Pamer EG
Am J Respir Crit Care Med; 2016 Aug; 194(4):450-63. PubMed ID: 26886180
[TBL] [Abstract][Full Text] [Related]
25. Profiling the Fungal Microbiome after Fecal Microbiota Transplantation for Graft-versus-Host Disease: Insights from a Phase 1 Interventional Study.
van Lier YF; Rolling T; Armijo GK; Zhai B; Haverkate NJE; Meijer E; Nur E; Blom B; Peled JU; van den Brink MRM; Hohl TM; Hazenberg MD; Markey KA
Transplant Cell Ther; 2023 Jan; 29(1):63.e1-63.e5. PubMed ID: 36280104
[TBL] [Abstract][Full Text] [Related]
26. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
27. The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD.
Markey KA; Schluter J; Gomes ALC; Littmann ER; Pickard AJ; Taylor BP; Giardina PA; Weber D; Dai A; Docampo MD; Armijo GK; Slingerland AE; Slingerland JB; Nichols KB; Brereton DG; Clurman AG; Ramos RJ; Rao A; Bush A; Bohannon L; Covington M; Lew MV; Rizzieri DA; Chao N; Maloy M; Cho C; Politikos I; Giralt S; Taur Y; Pamer EG; Holler E; Perales MA; Ponce DM; Devlin SM; Xavier J; Sung AD; Peled JU; Cross JR; van den Brink MRM
Blood; 2020 Jul; 136(1):130-136. PubMed ID: 32430495
[TBL] [Abstract][Full Text] [Related]
28. Multi-omics Analysis of a Fecal Microbiota Transplantation Trial Identifies Novel Aspects of Acute GVHD Pathogenesis.
Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Kazadi D; Halaweish H; Khan MH; Hoeschen A; Cao Q; Luo X; Kabage AJ; Lopez S; Ramamoorthy S; Holtan SG; Weisdorf DJ; Khoruts A; Staley C
Cancer Res Commun; 2024 Jun; 4(6):1454-1466. PubMed ID: 38767452
[TBL] [Abstract][Full Text] [Related]
29. Microbiota Predict Infections and Acute Graft-Versus-Host Disease After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation.
Margolis EB; Alfaro GM; Sun Y; Dallas RH; Allison KJ; Ferrolino J; Ross HS; Davis AE; Jia Q; Turner P; Mackay V; Morin CE; Triplett BM; Klein EJ; Englund JA; Tang L; Hayden RT
J Infect Dis; 2023 Aug; 228(5):627-636. PubMed ID: 37249910
[TBL] [Abstract][Full Text] [Related]
30. Specific gut microbiome members are associated with distinct immune markers in pediatric allogeneic hematopoietic stem cell transplantation.
Ingham AC; Kielsen K; Cilieborg MS; Lund O; Holmes S; Aarestrup FM; Müller KG; Pamp SJ
Microbiome; 2019 Sep; 7(1):131. PubMed ID: 31519210
[TBL] [Abstract][Full Text] [Related]
31. Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity.
Payen M; Nicolis I; Robin M; Michonneau D; Delannoye J; Mayeur C; Kapel N; Berçot B; Butel MJ; Le Goff J; Socié G; Rousseau C
Blood Adv; 2020 May; 4(9):1824-1832. PubMed ID: 32353108
[TBL] [Abstract][Full Text] [Related]
32. Acute Steroid-Refractory Gastrointestinal Graft-Versus-Host Disease Is Not Associated With Significant Differences in Gut Taxonomic Composition Compared to Steroid-Sensitive Gastrointestinal Graft-Versus-Host Disease Immediately Before Onset of Disease.
Zeng K; Brewster R; Kang JB; Tkachenko E; Brooks E; Bhatt AS; Fodor AA; Andermann TM
Transplant Cell Ther; 2024 Feb; 30(2):237.e1-237.e9. PubMed ID: 37944820
[TBL] [Abstract][Full Text] [Related]
33. Continuous pre- and post-transplant exposure to a disease-associated gut microbiome promotes hyper-acute graft-versus-host disease in wild-type mice.
Bowerman KL; Varelias A; Lachner N; Kuns RD; Hill GR; Hugenholtz P
Gut Microbes; 2020 Jul; 11(4):754-770. PubMed ID: 31928131
[TBL] [Abstract][Full Text] [Related]
34. Conditioning Regimens are Associated with Distinct Patterns of Microbiota Injury in Allogeneic Hematopoietic Cell Transplantation.
Shouval R; Waters NR; Gomes ALC; Zuanelli Brambilla C; Fei T; Devlin SM; Nguyen CL; Markey KA; Dai A; Slingerland JB; Clurman AG; Fontana E; Amoretti LA; Wright RJ; Hohl TM; Taur Y; Sung AD; Weber D; Hashimoto D; Teshima T; Chao NJ; Holler E; Scordo M; Giralt SA; Perales MA; Peled JU; van den Brink MRM
Clin Cancer Res; 2023 Jan; 29(1):165-173. PubMed ID: 36322005
[TBL] [Abstract][Full Text] [Related]
35. Associations between acute gastrointestinal GvHD and the baseline gut microbiota of allogeneic hematopoietic stem cell transplant recipients and donors.
Liu C; Frank DN; Horch M; Chau S; Ir D; Horch EA; Tretina K; van Besien K; Lozupone CA; Nguyen VH
Bone Marrow Transplant; 2017 Dec; 52(12):1643-1650. PubMed ID: 28967895
[TBL] [Abstract][Full Text] [Related]
36. Pre- and post-serial metagenomic analysis of gut microbiota as a prognostic factor in patients undergoing haematopoietic stem cell transplantation.
Kusakabe S; Fukushima K; Maeda T; Motooka D; Nakamura S; Fujita J; Yokota T; Shibayama H; Oritani K; Kanakura Y
Br J Haematol; 2020 Feb; 188(3):438-449. PubMed ID: 31566729
[TBL] [Abstract][Full Text] [Related]
37. A gut microbiota score predicting acute graft-versus-host disease following myeloablative allogeneic hematopoietic stem cell transplantation.
Han L; Zhao K; Li Y; Han H; Zhou L; Ma P; Fan Z; Sun H; Jin H; Jiang Z; Liu Q; Peng J
Am J Transplant; 2020 Apr; 20(4):1014-1027. PubMed ID: 31605563
[TBL] [Abstract][Full Text] [Related]
38. A single strain of Bacteroides fragilis protects gut integrity and reduces GVHD.
Sofi MH; Wu Y; Ticer T; Schutt S; Bastian D; Choi HJ; Tian L; Mealer C; Liu C; Westwater C; Armeson KE; Alekseyenko AV; Yu XZ
JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33554953
[TBL] [Abstract][Full Text] [Related]
39. Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.
Modi A; Rybicki L; Majhail NS; Mossad SB
Transpl Infect Dis; 2020 Feb; 22(1):e13217. PubMed ID: 31769584
[TBL] [Abstract][Full Text] [Related]
40. Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation.
Ingham AC; Kielsen K; Mordhorst H; Ifversen M; Aarestrup FM; Müller KG; Pamp SJ
Microbiome; 2021 Jun; 9(1):148. PubMed ID: 34183060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
